13F HOLDINGS REPORT
Catalys Pacific, LLC
Quarter ended Q3 2025 · Filed November 14, 2025 · Accession 0001104659-25-112029
Total Value
$351.4M
Positions
2
Other Managers
0
Confidential Omitted
No
Holdings (2)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Mineralys Therapeutics, Inc. | MLYS | 8,903,838 | $337.6M | 96.09% |
| 2 | Phathom Pharmaceuticals, Inc. | PHAT | 1,167,114 | $13.7M | 3.91% |